Managing myopia in children can be a different ball game in a public-facing clinic, opposed to those in a corporate, networked or independently-owned practice, new research shows.
Read More
Aussie myopia study reveals who benefits the most from low-dose atropine
Ancestry may be a factor in the effectiveness of low-dose atropine eye drops for myopia control, according to an Australian-first study conducted at the Lions Eye Institute (LEI).
Read More
Read More
Low-dose atropine EIKANCE secures first myopia TGA approval
The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children and young teenagers.
Read More
Read More